Skip to main content

Table 1 Median signature scores for each cancer type

From: Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs

Cancer Median NtAI Median LST Median HRD-LOH Average ranking Receives first line platinum*
OV 24 20 15 1 Yes
LUSC 20 13 17 2 Yes
BLCA 16 11 9 3 Yes
HNSC 15 9 12 3 Yes
LUAD 15 10 11 3 Yes
BRCA 12 8 8 6 No
SKCM 9 6 7 7 Some
STAD 10 7 5 7 Yes
COAD 8 5 5 9 Yes
GBM 4 3 4 10 No
PRAD 4 6 2 11 No
KIRC 4 3 3 12 No
UCEC 3 2 2 13 No$
LAML 1 0 0 14 No
THCA 0 0 0 15 No$
  1. *Based on treatment information available from Cancer Research UK, which can be found via http://www.cancerresearchuk.org/about-cancer/type/ $Does not receive chemotherapy as first line, but may receive platinum-based chemotherapy for high stage or recurrent disease.